ArticleFrontiers in immunology2024

Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma.

Doris K Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.